Diplomat Pharmacy, Inc. announced that Jeff Park, a member of the Diplomat Board of Directors, has been appointed Interim Chief Executive Officer, effective immediately. Mr. Park's appointment follows the retirement of Phil Hagerman, co-founder of Diplomat in 1975 and Chief Executive Officer and Chairman of Diplomat since 1991. Mr. Hagerman will remain as a member of the Diplomat Board and become Chairman Emeritus.

The Board has appointed Ben Wolin, independent Lead Director, as Chairman of the Diplomat Board, effective immediately. Mr. Hagerman's decision to retire as CEO was made with the support of the Board of Directors. Jeff Park has been a director since June 2017.

Prior to his appointment as Interim CEO, he was a member of the Audit Committee. Mr. Park was the Chief Operating Officer of OptumRx, a $75 billion entity resulting from the merger of Catamaran Corporation and OptumRx, UnitedHealth Group's free-standing pharmacy care services business from July 2015 until July 2016. Immediately prior to the merger, Mr. Park served as Catamaran's Executive Vice President, Operations since March 2014 and previously served as its Chief Financial Officer beginning in 2006.

Prior to serving as Chief Financial Officer, Mr. Park was a member of Catamaran's board of directors and was a Senior Vice President of Covington Capital Corporation, he joined in 1998. Benjamin Wolin has been a director since October 2015 and the independent Lead Director since February 2017. He is a member of the Audit Committee and the Nominating and Corporate Governance Committee of Diplomat.

Mr. Wolin was the co-founder, Chief Executive Officer and a member of the board of directors of Everyday Health, Incin December 2016. From September 1999 until December 2001, Mr. Wolin served as Vice President of Production and Technology for Beliefnet, Inc. Additionally, Mr. Wolin currently serves in an advisory capacity to several private technology and healthcare companies. Mr. Hagerman will serve as a consultant to the Company during the CEO search process to ensure a smooth transition.

As a consultant, Mr. Hagerman will advise the management team on the execution of Diplomat's growth plans and the integration of recent acquisitions.